The effects of green tea consumption on metabolic and anthropometric indices in patients with type 2 diabetes

Journal of Research in Medical Sciences

Volumn 18, Issue 12, 2013, Pages 1080-1086

  Mousavi, Ateke ^a   Vafa, Mohammadreza ^b   Neyestani, Tirang ^c   Khamseh, Mohammadebrahim ^b   Hoseini, Fatemeh ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anthropometric indices; Green tea; Metabolic indices; Type 2 diabetes

Indexed keywords

EID: 84893052372     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Shaw JE, Sicree RA, Zimmet RA. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14.
2. Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med 2006;354:997-9.
3. Kuyvenhoven JP, Meinders AE. Oxidative stress and diabetes mellitus pathogenesis of long-term complications. Eur J Intern Med 1999;10:9-19.
4. Maggio CA, Pi-Sunyer FX. The prevention and treatment of obesity: Application to type 2 diabetes. Diabetes Care 1997;20:1744-66.
5. Golozar A, Khademi H Kamangar F. Diabetes mellitus and its correlates in an Iranian adult population. PLoS One 2011;6:e26725.
6. Nathan DM, Buse JB, Davidson MB. Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203.
7. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Final report. Circulation 2002;106:3143-421.
8. Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: The Ohsaki study. JAMA 2006;296:1255-65.
9. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biol Med 1996;20:933-56.
10. Iso HC, Date K, Wakai M, Fukui A, Tamakoshi E. The relationship between green tea and total caffeine intake and risk for selfreported type 2 diabetes among Japanese adults. Ann Intern Med 2006;144:554-62.
11. Unno T, Tago M, Suzuki Y, Nozawa A, Sagesaka YM, Kakuda T, et al. Effect of tea catechins on postprandial plasma lipid responses in human subjects. Br J Nutr 2005;93:543-7.
12. Thielecke F, Boschmann M. The potential role of green tea catechins in the prevention of the metabolic syndrome. Phytochemistry 2009;70:11-24.
13. Nahas R, Moher M. Complementary and alternative medicine for the treatment of type 2 diabetes. Can Fam Physician 2009;55:591-6.
14. Chacko SM, Thambi PT, Kuttan R, Nishigaki I. Beneficial effects of green tea: A literature review. Chin Med 2010;5:1-9.
15. Ortsäter H, Grankvist N, Wolfram S, Kuehn N, Sjöholm A. Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice. Nutr Metab 2012;14:9-11.
16. Hodgson JM, Devine A, Puddey IB, Chan SY, Beilin LJ, Prince RL. Tea intake is inversely related to blood pressure in older women. J Nutr 2003;133:2883-6.
17. Bracco D, Ferrarra JM, Arnaud MJ, Jequier E, Schutz Y. Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women. Am J Physiol 1995;269:E671-8.
18. Lee M, Kim C, Kim Y. Green tea-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-Induced obese mice. Ann Nutr Metab 2009;54:151-7.
19. Dulloo AG, Duret C, Rohrer D, Girardier L, Mensi N, Fathi M, et al. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr 1999;70:1040-5.
20. Koo SI, Noh SK. Green tea as inhibitor of the intestinal absorption of lipids: Potential mechanism for its lipid-lowering effect. J Nutr Biochem 2007;18:179-83.
21. Vinson JA, Dabbagh YA. Effect of green and black tea supplementation on lipids, lipid oxidation and fibrinogen in the hamster: Mechanisms for the epidemiological benefits of tea drinking. FEBS Lett 1998;433:44-6.
22. McNamara JR, Cohn JS, Wilson PW, Schaefer EJ. Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk. Clin Chem 1990;36:36-42.
23. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978;90:37-43.
24. Neyestani TR, Shariatzadeh N, Gharavi A, Kalayi A, Khalaji N. Physiological dose of lycopene suppressed oxidative stress and enhanced serum levels of immunoglobulin M in patiens with type 2 diabetes mellitus: A possible role in the prevention of long-term complications. J Endocrinol Invest 2007;30:833-8.
25. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": The FRAP assay. Analytical Biochem 1996;239:70-6.
26. Nagao T, Hase T, Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity 2007;15:1473-83.
27. Rudelle S, Ferruzzi MG, Cristiani I, Moulin J, Macé K, Acheson KJ, et al. Effect of a thermogenic beverage on 24-hour energy metabolism in humans. Obesity 2007;15:349-55.
28. Kao YH, Chang HH, Lee MJ, Chen CL. Tea, obesity, and diabetes. Mol Nutr Food Res 2006;50:188-210.
29. Hsu CH, Liao YL, Lin SC, Tsai TH, Huang CJ, Chou P. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Altern Med Rev 2011;16:157-63.
30. Klaus S, Pultz S, Thone-Reineke C, Wolfram S. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int J Obes 2005;29:615-23.
31. Murase T, Nagasawa A, Suzuki J, Hase T, Tokimitsu I. Beneficial effects of tea catechins on diet-induced obesity: Stimulation of lipid catabolism in the liver. Int Obes Relat Metab Disord 2002;26:1459-64.
32. Chantre P, Lairon D. Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Phytomedicine 2002;9:3-8.
33. Dulloo AG, Seydoux J, Girardier L, Chantre P, Vandermander J. Green tea and thermogenesis: Interactions between catechinpolyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord 2000;24:252-8.
34. Nagao T, Komine Y, Soga S, Meguro S, Hase T, Tanaka Y, et al. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am J Clin Nutr 2005;81:122-9.
35. Chan CC, Koo MW, Ng EH, Tang OS, Yeung WS, Ho PC. Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome-a randomized placebo-controlled trial. J Soc Gynecol Investig 2006;13:63-8.
36. National Institutes of Health. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) [NIH Publication 01-3670]. Bethesda, MD: National Institutes of Health; 2001.
37. van Dam RM, Naidoo N, Landberg R. Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: Review of recent findings. Curr Opin Lipidol 2013;24:25-33.
38. Yang YC, Lu FH, Wu JS, Wu CH, Chang CJ. The protective effect of habitual tea consumption on hypertension. Arch Intern Med 2004;164:1534-40.
39. Potenza MA, Marasciulo FL, Tarquinio M, Tiravanti E, Colantuono G, Federici A, et al. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I / R injury in SHR. Am J Physiol Endocrinol Metab 2007;292:E1378-87.
40. Sabu MC, Smitha K, Kuttan R. Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J Ethnopharmacol 2002;83:109-16.
41. Li C, Allen A, Kwagh J, Doliba NM, Qin W, Najafi H, et al. Green tea polyphenols modulate insulin secretion by inhibiting glutamate dehydrogenase. J Biol Chem 2006;281:10214-21.
42. Yan J, Zhao Y, Suo S, Liu Y, Zhao B. Green tea catechins ameliorate adipose insulin resistance by improving oxidative stress. Free Radic Biol Med 2012;52:1648-57.
43. Ryan EA, Imes S, Wallace C, Jones S. Herbal tea in the treatment of diabetes mellitus. Clin Invest Med 2000;23:311-7.
44. Ryu OH, Lee J, Lee KW, Kim HY, Seo JA, Kim SG, et al. Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract 2006;71:356-8.
45. Josic J, Olsson AT, Wickeberg J, Lindstedt S, Hlebowicz J. Does green tea affect postprandial glucose, insulin and satiety in healthy subjects: A randomized controlled trial. Nutr J 2010;63:1-8.
46. Raederstorff DG, Schlachter MF, Elste V, Weber P. Effect of EGCG on lipid absorption and plasma lipid levels in rats. J Nutr Biochem 2003;14:326-32.
47. Anandh Babu PV, Sabitha KE, Shyamaladevi CS. Green tea extract impedes dyslipidaemia and develo pment of cardiac dysfunction in streptozotocin-diabetic rats. Clin Exp Pharmacol Physiol 2006;33:1184-9.
48. Haidari F, Shahi MM, Zarei M, Rafiei H, Omidian K. Effect of green tea extract on body weight, serum glucose and lipid profile in streptozotocin-induced diabetic rats. A dose response study. Saudi Med J 2012;33:128-33.
49. Maron DJ, Lu GP, Cai NS, Wu ZG, Li YH, Chen H, et al. Cholesterollowering effect of a theaflavin-enriched green tea extract: A randomized controlled trial. Arch Intern Med 2003;163:1448-53.
50. Antonello M, Montemurro D, Bolognesi M. Prevention of hypertension, cardiovascular damage and endothelial dysfunction with green tea extracts. Am J Hypertens 2007;20:1321-8.
51. Tipoe GL, Leung TM, Hung MW, Fung ML. Green tea polyphenols as an anti-oxidant and anti inflammatory agent for cardiovascular protection. Cardiovasc Hematol Disord Drug Targets 2007;7:135-44.
52. Jazayery A, Jalali M, Keshavarz SA, Shakouri Mahmoudabadi MM, Eshraghian MR, Saboor Yaraghi AA, et al. Inflammatory biomarkers, antioxidant enzyme activities, and oxidative stress in Iranian male patients with type 2 diabetes mellitus: Effects of eicosapentaenoic acid and vitamin C supplementation. J Res Med Sci 2012;17:S38-41.
53. Yokozawa T, Nakagawa T, Kitani K. Antioxidative activity of green tea polyphenol in cholesterol-fed rats. J Agric Food Chem 2002;50:3549-52.
54. Coimbra S, Castro E, Rocha-Pereira P, Rebelo I, Rocha S, Santos-Silva A. The effect of green tea in oxidative stress. Clin Nutr 2006;25:790-6.
55. Freese R, Basu S, Hietanen E, Nair J, Nakachi K, Bartsch H, et al. Green tea extract decreases plasma malondialdehyde concentration but does not affect other indicators of oxidative stress, nitric oxide production, or hemostatic factors during a highlinoleic acid diet in healthy females. Eur J Nutr 1999;38:149-57.